Medindia

X

USFDA Gives the Nod to Lupin to Market Its Suprax Capsules

by Savitha C Muppala on  July 6, 2012 at 4:43 PM Drug News   - G J E 4
Drug maker Lupin announced that it has received the new drug application (NDA) approval from the US health regulator to market its Suprax capsules in the strength of 400 mg in America.
 USFDA Gives the Nod to Lupin to Market Its Suprax Capsules
USFDA Gives the Nod to Lupin to Market Its Suprax Capsules
Advertisement

Lupin Group President & ED Nilesh Gupta said: "The new dosage form will add to our growing Suprax franchise and gives healthcare providers and patients a new formulation to treat the indicated infections".

Advertisement


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All